Press Coverage

Chicago Drugmaker Recalls Neuromuscular Drug Due to Labeling Error

News brief about recall of cisatracurium due to some vials in lot being incorrectly labeled as phenylephrine mentions ISMP’s alert to practitioners as well as Food and Drug Administration (FDA) news release.

For the full text, visit Becker’s Hospital Review online.

More News

Since COVID-19 vaccines were granted emergency use authorization, The Institute for Safe Medication Practices (ISMP) has received reports of errors related to storage, preparation, and administration. Because COVID-19 vaccine errors can result in reduced effectiveness, and other safety implications